A2 Biotherapeutics Inc.
Clinical trials sponsored by A2 Biotherapeutics Inc., explained in plain language.
-
Smart cell therapy aims to target cancer while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of cell therapy called A2B395 for adults with advanced solid tumors that have spread or returned. The therapy uses modified immune cells designed to specifically kill cancer cells while protecting the patient's healthy cells. The main goals are to…
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Smart cell therapy aims to target advanced cancers while sparing healthy tissue
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy for adults with advanced solid tumors that have come back or spread. The therapy, called Tmod CAR T, is designed to recognize and kill cancer cells while using a built-in safety switch to protect the patient's healthy …
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Scientists collect cancer patients' cells for future 'living drug' therapy
Knowledge-focused Recruiting nowThis study aims to collect tumor tissue and blood cells from people with advanced solid tumors to prepare for future CAR T-cell therapy. Researchers will analyze the cancer tissue to understand how tumors hide from the immune system and collect participants' own immune cells thro…
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC